Effect of restrictive fluid therapy with hydroxyethyl starch during esophagectomy on postoperative outcomes: a retrospective cohort study.

Jun-Young JoWook-Jong KimDae-Kee ChoiHyeong Ryul KimEun-Ho LeeIn-Cheol Choi

Published in: BMC surgery (2019)

Although hydroxyethyl starch administration reduces the total fluid infusion amount during esophageal surgery for cancer, intravenous hydroxyethyl starch infusion is associated with an increasing risk of postoperative composite complications.

Keyphrases

patients undergoing
low dose
minimally invasive
papillary thyroid
lactic acid
coronary artery bypass
high dose
risk factors
type diabetes
stem cells
coronary artery disease
skeletal muscle
weight loss
insulin resistance
replacement therapy